References
- Sanz MA, Grimwade D, Tallman MS, Lowenberg B, et al. Management of acute promyelocytic leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009;113(9):1875–91.
- Lo-Coco F, Avvisati G, Orlando SM, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369:111–121.
- Park JH, Qiao B, Panageas KS, Schymura MJ, et al. Early death rate in APL remains high despite all-trans retinoic acid. Blood. 2011;118(5):1248–1254.
- Estey E, Guillermo GM, Manero AF, Faderl S, et al. Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. Blood. 2006;107(9):3469–3473.